PANREAC presents a new line of excipients for the pharmaceutical industry according to the IPEC guide
For seven decades PANREAC has succeed in satisfying the needs of their costumers thanks to their extensive experience, their constant product innovation and quality research.
PANREAC, since its founding in 1941 is one of the Spanish leading companies specialized in the manufacturing of reagents for laboratory analysis, excipients and bulk chemicals to be used as raw materials in the pharmaceutical, cosmetic and food industries.
PANREAC has become a benchmark company in the pharmaceutical manufacturing process for their high quality standards established from the start. Since the company’s beginnings, they offered high purity products PRS for Pharmaceutical applications, becoming later the “PRS-CODEX’, an important level of commitment with the main pharmacopeias. Over last year they have launched a new line of excipients for the pharmaceutical industry fulfilling the guidelines of IPEC.
At the moment, Panreac Pharma counts with more than 300 raw materials for the pharmaceutical and biotechnology industry to be used as excipients or during the manufacturing process.
High Standards of Quality
The excipients are the main ingredient of the medicines in terms of volume and weight; therefore, they have an important function on the final product. For this reason, PANREAC has adopted the IPEC-PQG GMP guide for pharmaceutical excipients (2006), to ensure product consistent conformity through and integral control policy which Panreac has integrated into its manufacturing processes.
The line has an incredible detailed process description including registration, validation and release procedures and also supports supplier audits, upstream and downstream traceability and has a production sample storage. Furthermore, PANREAC has trained specialized workforce to assure the best quality and safety for the pharmaceutical industry and its potential consumers, offering maximum purity, reliability and a firm commitment to society that is finally translated into success and progress. PANREAC has built an exclusive “Clean Room Panreac Pharma” aimed just to develop excipients within strict work conditions in terms of hygiene and contamination control.
PANREAC also disposes of the ISO 9001:2008 on quality management, ISO 14002:2004 on environmental protection and OHSAS 18001:2007 on the safety and health at work, three more commitments that justify one of their main company values: be at the leading edge of quality assurance in the sector.
Fast market development
For seven decades PANREAC has succeed in satisfying the needs of their costumers thanks to their extensive experience, their constant product innovation and quality research.
Thereby, in order to respond the constant increasing market demands, PANREAC disposes of a 15000 m2 high-tech production plant near Barcelona that allows them to optimize flexibility and efficiency in their production. Moreover, since 2008 they developed a new 8000 m2 technologically equipped warehouse to provide the best service to customers and distributors.
Particularly, the company has worked hard to truly expand their products and services internationally. So, for this reason, in 1999 they opened their first two subsidiaries in France and Portugal. Lately in 2007 PANREAC bought the Italian company Nova Chimica, allowing them to get faster in the European market. In 2010 Panreac became part of the chemical division (performance polymers and fluids group) of Illinois Tool Works (ITW), an $18 billion per year U.S. industrial conglomerate.
Nowadays, PANREAC exports their products to more than 80 countries in the world, thanks to their growing and expanding distribution network.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance